Ali Reyhanian

Ali Reyhanian

Auto-generated profile, based on publicly available information

Ali Reyhanian

Student Research committee, Shahrekord University of Medical Sciences, Shahrekord, Iran

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2020 in Journal of Nephropathology
Verified
Journal Article
Open access
PDF file
Elahe Aleebrahim-DehkordiElahe Aleebrahim-Dehkordi
Elahe Aleebrahim-Dehkordi
ARAli Reyhanian
Ali Reyhanian
SSShirin Saberianpour
Shirin Saberianpour
AHali hassanpourdehkordi
ali hassanpourdehkordi
Coronaviruses are a large family of viruses that can cause a variety of diseases in humans. Some coronaviruses cause only mild illnesses like the common cold. While, some coronaviruses such as SARS-CoV (SARS-associated coronavirus) and Middle East respiratory syndrome coronavirus (MERS-CoV) have, in recent years, been able to cause severe respiratory involvement (pneumonia), leading to death in several patients. By identifying the genomic sequence of the new human coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) it has been revealed that it belongs to the beta coronavirus genus. COVID-19 appears to be transmitted by a mechanism similar to the influenza virus via person to person, sneezing coughing, or contact with the secretions of infected patients. Early symptoms of these respiratory viruses include fever, cough, and shortness of breath, with an incubation period of 2-14 days. SARS-CoV-2 is an acute respiratory disease that initially causes lung damage. SARS-CoV-2 can affect other organs, including the kidneys. Kidney damage may be caused by alterations that occur during coronavirus infection. It seems that low-oxygen delivery to tissues like the kidney in the setting of this disease may lead to ischemic damage of the kidney. Considering the importance of the kidneys, as one, this review study aimed to investigate the effect of the new coronavirus on the kidneys and its role in the development of renal failure.

1 January 2020 in Journal of Pharmaceutical Negative Results
Verified
Journal Article
Closed access
PDF file
MRMahmoud Rafieian-kopaei
Mahmoud Rafieian-kopaei
EAElaheh Aleebrahim-Dehkordy
Elaheh Aleebrahim-Dehkordy
BZBehnam Zamanzad
Behnam Zamanzad
FDFatemeh Deris
Fatemeh Deris
ASAbolghasem Sharifih
Abolghasem Sharifih
ARAli Reyhanian
Ali Reyhanian
Objective: The aim of this study was to determine the antimicrobial effect of Hibiscus sabdariffa extract on oral and dental bacterial pathogens. Materials and Methods: In this study, the extract of H. sabdariffa was isolated by maceration with chloroform and concentrated by a rotary evaporator. The antimicrobial effects were examined using broth microdilution, and minimum inhibitory concentration and minimum bactericidal concentration values were determined. Next, the effect of different concentrations of extract on the growth of Streptococcus pyogenes, Streptococcus mutans, and Streptococcus salivarius was investigated by disc diffusion method. Finally, the data were analyzed using SPSS 16 software (SPSS Inc., 233 South Wacker Drive, 11th Floor, Chicago, IL 60606-6412), and the results were presented as mean (± standard deviation). Results: The results of this study showed that the chloroform extract of H. sabdariffa had inhibitory and bactericidal effects on three bacteria in both broth microdilution and disc diffusion methods. In broth microdilution, S. mutans and S. salivarius were more resistant to H. sabdariffa extract than S. pyogenes. In disc diffusion method, the highest inhibitory effect of the extract was observed on S. pyogenes at 25 μg/ml with a growth inhibition zone diameter of 13.03 ± 0.15 mm. Conclusion: According to the results of this study, it can be argued that the chloroform extract of H. sabdariffa is effective in inhibiting S. pyogenes, S. mutans, and S. salivarius in both broth microdilution and disc diffusion methods.